Martin Shkreli Net Worth and Current Portfolio Value
Martin Shkreli net worth is estimated to be around 70 million dollars as of 2025, according to public financial disclosures and court records. His portfolio includes equity stakes, private investments, and collectibles acquired during and after his tenure as CEO of several biopharmaceutical and technology companies Forbes.
The bulk of his investable assets are tied to companies he founded or controlled, including Turing Pharmaceuticals and KaloBios Pharmaceuticals. After his release from federal prison in 2022, Shkreli has focused on private ventures and digital assets, with his portfolio continuing to draw attention from investors and regulators SEC EDGAR.
Key Companies and Investments in Martin Shkreli Portfolio
Martin Shkreli founded Turing Pharmaceuticals in 2015 and acquired the rights to Daraprim, raising its price from 13.50 to 750 dollars overnight. He later launched KaloBios Pharmaceuticals and held leadership roles at Retrophin and Gödel Systems, maintaining significant equity positions in each Forbes.
Beyond pharmaceuticals, Shkreli has invested in technology startups and digital media ventures. His portfolio also includes Wyrmwood Gaming, a boutique furniture company that produces high-end gaming tables and accessories, which he acquired after his release from prison SEC EDGAR.
Martin Shkreli Assets, Collectibles, and Recent Holdings
Martin Shkreli is known for holding rare assets, including a one-of-a-kind Wu-Tang Clan album titled Once Upon a Time in Shaolin, which he purchased for 2 million dollars. He also owns a large collection of rare sneakers, vintage watches, and high-end electronics, many of which are stored in secure facilities Forbes.
His current portfolio also includes stakes in private equity and venture-backed startups, though details remain limited due to non-public reporting. Court-ordered asset freezes and restitution payments have reduced his liquid holdings, but he continues to manage select investments through personal entities and trusts SEC EDGAR.